These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 22447143)
1. The relationship of epicardial adipose tissue thickness to clinical and biochemical features in women with polycystic ovary syndrome. Aydogdu A; Uckaya G; Tasci I; Baysan O; Tapan S; Bugan B; Serdar M; Akbulut H; Aydogan U; Sonmez A; Aydogdu S; Kutlu M Endocr J; 2012; 59(6):509-16. PubMed ID: 22447143 [TBL] [Abstract][Full Text] [Related]
2. Epicardial adipose tissue thickness and NGAL levels in women with polycystic ovary syndrome. Sahin SB; Cure MC; Ugurlu Y; Ergul E; Gur EU; Alyildiz N; Bostan M J Ovarian Res; 2014 Feb; 7():24. PubMed ID: 24528623 [TBL] [Abstract][Full Text] [Related]
3. The relationship between epicardial adipose tissue thickness and oxidative stress parameters in patients with isolated polycystic ovary syndrome. Demir B; Cengiz H; Ungan I; Gedikbasi A; Karakoç G; Demir E; Demir N Gynecol Endocrinol; 2015 Jul; 31(7):531-5. PubMed ID: 26340353 [TBL] [Abstract][Full Text] [Related]
4. High-molecular-weight adiponectin is inversely associated with sympathetic activity in polycystic ovary syndrome. Shorakae S; Abell SK; Hiam DS; Lambert EA; Eikelis N; Jona E; Sari CI; Stepto NK; Lambert GW; de Courten B; Teede HJ Fertil Steril; 2018 Mar; 109(3):532-539. PubMed ID: 29428305 [TBL] [Abstract][Full Text] [Related]
5. The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome. Arpaci D; Gurkan Tocoglu A; Yilmaz S; Ergenc H; Tamer A; Keser N; Gunduz H J Ovarian Res; 2015 Nov; 8():71. PubMed ID: 26545735 [TBL] [Abstract][Full Text] [Related]
6. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome. Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948 [TBL] [Abstract][Full Text] [Related]
7. Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome. Chang CY; Chen MJ; Yang WS; Yeh CY; Ho HN; Chen SU; Yang YS Taiwan J Obstet Gynecol; 2012 Dec; 51(4):583-90. PubMed ID: 23276562 [TBL] [Abstract][Full Text] [Related]
8. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome. Lauria PB; Del Puerto HL; Reis AM; Candido AL; Reis FM J Clin Endocrinol Metab; 2013 Dec; 98(12):4882-9. PubMed ID: 24057296 [TBL] [Abstract][Full Text] [Related]
9. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance. O'Connor A; Phelan N; Tun TK; Boran G; Gibney J; Roche HM J Clin Endocrinol Metab; 2010 Mar; 95(3):1378-85. PubMed ID: 20080859 [TBL] [Abstract][Full Text] [Related]
10. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study. Singh S; Akhtar N; Ahmad J Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540 [TBL] [Abstract][Full Text] [Related]
11. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome. Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322 [TBL] [Abstract][Full Text] [Related]
12. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507 [TBL] [Abstract][Full Text] [Related]
13. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646 [TBL] [Abstract][Full Text] [Related]
14. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Ardawi MS; Rouzi AA Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640 [TBL] [Abstract][Full Text] [Related]
16. Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity. Aydogdu A; Tasci I; Kucukerdonmez O; Tapan S; Aydogdu S; Aydogan U; Sonmez A; Yazici M; Azal O Gynecol Endocrinol; 2013 Feb; 29(2):152-5. PubMed ID: 22849614 [TBL] [Abstract][Full Text] [Related]
17. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome]. Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713 [TBL] [Abstract][Full Text] [Related]
18. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance]. Wan DH; Fan P; Bai H; Song Q; Liu HW Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923 [TBL] [Abstract][Full Text] [Related]
19. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Li X; Lin JF Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817 [TBL] [Abstract][Full Text] [Related]
20. The high-molecular weight multimer form of adiponectin is a useful marker of polycystic ovary syndrome in Bahraini Arab women. Al-Awadi AM; Sarray S; Arekat MR; Saleh LR; Mahmood N; Almawi WY Clin Nutr ESPEN; 2016 Jun; 13():e33-e38. PubMed ID: 28531566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]